PL3006427T3 - Fluorowany związek estru kwasu benzilowego i jego sole - Google Patents
Fluorowany związek estru kwasu benzilowego i jego soleInfo
- Publication number
- PL3006427T3 PL3006427T3 PL14804112T PL14804112T PL3006427T3 PL 3006427 T3 PL3006427 T3 PL 3006427T3 PL 14804112 T PL14804112 T PL 14804112T PL 14804112 T PL14804112 T PL 14804112T PL 3006427 T3 PL3006427 T3 PL 3006427T3
- Authority
- PL
- Poland
- Prior art keywords
- salt
- acid ester
- ester compound
- benzilic acid
- fluorinated
- Prior art date
Links
- -1 Fluorinated benzilic acid ester compound Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013114142 | 2013-05-30 | ||
| PCT/JP2014/064216 WO2014192847A1 (ja) | 2013-05-30 | 2014-05-29 | 新規なフッ素化ベンジル酸エステル化合物又はその塩 |
| EP14804112.2A EP3006427B1 (en) | 2013-05-30 | 2014-05-29 | Fluorinated benzilic acid ester compound and salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3006427T3 true PL3006427T3 (pl) | 2018-03-30 |
Family
ID=51988870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14804112T PL3006427T3 (pl) | 2013-05-30 | 2014-05-29 | Fluorowany związek estru kwasu benzilowego i jego sole |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9718776B2 (pl) |
| EP (1) | EP3006427B1 (pl) |
| JP (1) | JP6045691B2 (pl) |
| KR (1) | KR101745814B1 (pl) |
| CN (1) | CN105283444B (pl) |
| AU (1) | AU2014271739B2 (pl) |
| CA (1) | CA2914147C (pl) |
| ES (1) | ES2652555T3 (pl) |
| MX (1) | MX2015016310A (pl) |
| MY (1) | MY181470A (pl) |
| PH (1) | PH12015502498B1 (pl) |
| PL (1) | PL3006427T3 (pl) |
| RU (1) | RU2632881C2 (pl) |
| SG (1) | SG11201508840RA (pl) |
| TW (1) | TWI571459B (pl) |
| WO (1) | WO2014192847A1 (pl) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD139212A1 (de) * | 1978-10-09 | 1979-12-19 | Christian Starke | Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten |
| JPH0611758B2 (ja) | 1985-08-14 | 1994-02-16 | 大鵬薬品工業株式会社 | ベンジル酸−4−ピペリジルエステル誘導体 |
| JPH0669068B2 (ja) | 1985-08-30 | 1994-08-31 | 株式会社東芝 | 多層配線の製造方法 |
| JP2549183B2 (ja) * | 1990-02-26 | 1996-10-30 | 三共株式会社 | アクリル酸ピペリジルエステル誘導体の製法 |
| DE10129832A1 (de) * | 2001-06-17 | 2003-07-10 | Berolina Drug Dev Ab Svedala | Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel |
-
2014
- 2014-05-29 ES ES14804112.2T patent/ES2652555T3/es active Active
- 2014-05-29 MY MYPI2015703935A patent/MY181470A/en unknown
- 2014-05-29 RU RU2015156609A patent/RU2632881C2/ru active
- 2014-05-29 US US14/889,042 patent/US9718776B2/en active Active
- 2014-05-29 EP EP14804112.2A patent/EP3006427B1/en active Active
- 2014-05-29 WO PCT/JP2014/064216 patent/WO2014192847A1/ja not_active Ceased
- 2014-05-29 TW TW103118787A patent/TWI571459B/zh active
- 2014-05-29 JP JP2015519921A patent/JP6045691B2/ja active Active
- 2014-05-29 SG SG11201508840RA patent/SG11201508840RA/en unknown
- 2014-05-29 MX MX2015016310A patent/MX2015016310A/es active IP Right Grant
- 2014-05-29 CA CA2914147A patent/CA2914147C/en active Active
- 2014-05-29 CN CN201480030790.6A patent/CN105283444B/zh active Active
- 2014-05-29 PL PL14804112T patent/PL3006427T3/pl unknown
- 2014-05-29 AU AU2014271739A patent/AU2014271739B2/en active Active
- 2014-05-29 KR KR1020157036361A patent/KR101745814B1/ko active Active
-
2015
- 2015-10-29 PH PH12015502498A patent/PH12015502498B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2914147C (en) | 2018-08-14 |
| SG11201508840RA (en) | 2015-11-27 |
| HK1217332A1 (zh) | 2017-01-06 |
| EP3006427B1 (en) | 2017-11-15 |
| TW201533026A (zh) | 2015-09-01 |
| PH12015502498A1 (en) | 2016-02-22 |
| RU2015156609A (ru) | 2017-07-06 |
| WO2014192847A1 (ja) | 2014-12-04 |
| PH12015502498B1 (en) | 2016-02-22 |
| BR112015029251A2 (pt) | 2017-07-25 |
| CA2914147A1 (en) | 2014-12-04 |
| ES2652555T3 (es) | 2018-02-05 |
| EP3006427A4 (en) | 2017-01-11 |
| KR101745814B1 (ko) | 2017-06-12 |
| MY181470A (en) | 2020-12-22 |
| US20160115129A1 (en) | 2016-04-28 |
| AU2014271739A1 (en) | 2015-12-03 |
| CN105283444B (zh) | 2017-06-16 |
| KR20160013148A (ko) | 2016-02-03 |
| JP6045691B2 (ja) | 2016-12-14 |
| US9718776B2 (en) | 2017-08-01 |
| TWI571459B (zh) | 2017-02-21 |
| EP3006427A1 (en) | 2016-04-13 |
| MX2015016310A (es) | 2016-03-03 |
| JPWO2014192847A1 (ja) | 2017-02-23 |
| CN105283444A (zh) | 2016-01-27 |
| AU2014271739B2 (en) | 2016-07-28 |
| RU2632881C2 (ru) | 2017-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201805629B (en) | Leucine and nicotinic acid reduces lipid levels | |
| IL274454A (en) | Hyaluronic acid preparations including mepivacaine | |
| PL2997117T3 (pl) | Zastosowanie estru | |
| RU2016118399A3 (en) | 4-aminomethylbenzoic acid derivative | |
| ME03398B (me) | Spojevi dimetilbenzojeve kiseline | |
| SG11201508542SA (en) | Dicarboxylic acid compound | |
| SI2975022T1 (sl) | Novi derivati hidroksamske kisline ali soli le-teh | |
| ZA201506745B (en) | Guanidinobenzoic acid ester compound | |
| IL246230A0 (en) | Amines thf quinazoline as pde1 inhibitors | |
| PL3006427T3 (pl) | Fluorowany związek estru kwasu benzilowego i jego sole | |
| EP3000807A4 (en) | Mercaptonicotinic acid compound and preparation method and use thereof | |
| EP2984062A4 (en) | HYDROLYSIS OF AN ESTER COMPOUND | |
| GB201402985D0 (en) | Active tagging | |
| AU2013072V (en) | Pink Frost Illicium floridanum |